Pfizer (PFE) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

PFE Stock Forecast


Pfizer (PFE) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $32.60, with a high of $34.00 and a low of $32.00. This represents a 26.21% increase from the last price of $25.83.

$25 $26 $27 $28 $29 $30 $31 $32 $33 $34 High: $34 Avg: $32.6 Low: $32 Last Closed Price: $25.83

PFE Stock Rating


Pfizer stock's rating consensus is Hold, based on 21 Wall Street analysts. The breakdown includes 1 Strong Buy (4.76%), 8 Buy (38.10%), 11 Hold (52.38%), 1 Sell (4.76%), and 0 Strong Sell (0.00%).

Hold
Total 21 0 1 11 8 1 Strong Sell Sell Hold Buy Strong Buy

PFE Price Target Upside V Benchmarks


TypeNameUpside
StockPfizer26.21%
SectorHealthcare Stocks 23.08%
IndustryDrug Manufacturers - General Stocks18.59%

Price Target Trends


1M3M12M
# Anlaysts-111
Avg Price Target-$32.00$34.00
Last Closing Price$25.83$25.83$25.83
Upside/Downside-23.89%31.63%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2537131-24
Jan, 2538131-25
Dec, 2438131-25
Nov, 24411141131
Oct, 2441114-130
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 18, 2024Robyn KarnauskasTruist Financial$32.00$25.8923.60%23.89%
Oct 30, 2024Chris ShibutaniGoldman Sachs$33.00$28.4615.95%27.76%
Oct 17, 2024Courtney BreenBernstein$32.00$29.677.85%23.89%
Sep 25, 2024Carter GouldBarclays$32.00$28.9310.61%23.89%
Aug 07, 2024Narumi NakagiriDaiwa$34.00$28.8517.85%31.63%
Jul 31, 2024Mohit BansalWells Fargo$30.00$31.39-4.43%16.14%
Jul 31, 2024Chris ShibutaniGoldman Sachs$34.00$31.398.31%31.63%
Jul 30, 2024Vamil DivanGuggenheim$36.00$30.7217.19%39.37%
Jul 10, 2024Carter GouldBarclays$30.00$27.728.23%16.14%
May 22, 2024Evan SeigermanBMO Capital$36.00$29.6021.62%39.37%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Oct 30, 2024Goldman SachsBuyBuyhold
Oct 23, 2024Wells FargoMarket PerformMarket Performhold
Oct 17, 2024BernsteinMarket Performinitialise
Sep 25, 2024BarclaysEqual-WeightEqual-Weighthold
Sep 20, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 13, 2024BMO CapitalOutperformOutperformhold
Jul 31, 2024Wells FargoEqual-WeightEqual-Weighthold
Jul 31, 2024BarclaysEqual-WeightEqual-Weighthold
Jul 31, 2024Goldman SachsBuyBuyhold
Jul 30, 2024GuggenheimBuyinitialise

Financial Forecast


EPS Forecast

$0 $1 $2 $3 $4 $5 $6 $7 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.25$3.92$5.59$0.37-----
Avg Forecast$2.83$4.21$6.50$1.55$2.92$2.91$3.01$2.98$2.85
High Forecast$2.73$4.06$6.29$1.48$2.73$2.46$2.58$2.24$2.77
Low Forecast$2.93$4.35$6.64$1.66$3.12$3.03$3.92$3.37$2.91
Surprise %-55.83%-6.89%-14.00%-76.13%-----

Revenue Forecast

$40B $53B $66B $79B $92B $105B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$41.91B$81.29B$100.33B$58.50B-----
Avg Forecast$48.20B$81.76B$100.34B$58.78B$63.08B$63.08B$63.06B$62.33B$59.90B
High Forecast$46.90B$79.56B$97.80B$58.53B$62.67B$62.46B$62.99B$62.17B$58.66B
Low Forecast$49.46B$83.89B$101.97B$59.18B$63.63B$63.93B$63.14B$62.50B$60.82B
Surprise %-13.06%-0.58%-0.01%-0.48%-----

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.02B$21.98B$31.37B$2.12B-----
Avg Forecast$8.71B$24.02B$18.44B$2.13B$16.71B$15.66B$18.56B$12.93B$16.27B
High Forecast$6.97B$23.18B$14.75B$1.71B$15.60B$14.02B$14.75B$12.79B$15.83B
Low Forecast$10.45B$24.84B$22.12B$2.56B$17.81B$17.30B$22.37B$19.23B$16.59B
Surprise %-19.40%-8.52%70.16%-0.70%-----

PFE Forecast FAQ


Is Pfizer stock a buy?

Pfizer stock has a consensus rating of Hold, based on 21 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 8 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Pfizer is a neutral investment for most analysts.

What is Pfizer's price target?

Pfizer's price target, set by 21 Wall Street analysts, averages $32.6 over the next 12 months. The price target range spans from $32 at the low end to $34 at the high end, suggesting a potential 26.21% change from the previous closing price of $25.83.

How does Pfizer stock forecast compare to its benchmarks?

Pfizer's stock forecast shows a 26.21% upside, outperforming the average forecast for the healthcare stocks sector (23.08%) and outperforming the drug manufacturers - general stocks industry (18.59%).

What is the breakdown of analyst ratings for Pfizer over the past three months?

  • February 2025: 12.50% Strong Buy, 29.17% Buy, 54.17% Hold, 4.17% Sell, 0% Strong Sell.
  • January 2025: 12.00% Strong Buy, 32.00% Buy, 52.00% Hold, 4.00% Sell, 0% Strong Sell.
  • December 2024: 12.00% Strong Buy, 32.00% Buy, 52.00% Hold, 4.00% Sell, 0% Strong Sell.

What is Pfizer’s EPS forecast?

Pfizer's average annual EPS forecast for its fiscal year ending in December is $2.92 for 2024, a 689.19% increase from the reported $0.37 in 2023. The prediction for 2025 is $2.91, $3.01 for 2026, $2.98 for 2027, and $2.85 for 2028.

What is Pfizer’s revenue forecast?

Pfizer's average annual revenue forecast for its fiscal year ending in December is $63.08B for 2024, a 7.83% increase from the reported $58.5B in 2023. The forecast for 2025 is $63.08B, $63.06B for 2026, $62.33B for 2027, and $59.9B for 2028.

What is Pfizer’s net income forecast?

For its fiscal year ending in December, Pfizer's average annual net income forecast is $16.71B for 2024, reflecting an 688.52% increase from the reported $2.12B in 2023. The projection for 2025 is $15.66B, $18.56B for 2026, $12.93B for 2027, and $16.27B for 2028.